Drug profile · INN
capromab pendetide
PROSTASCINT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
capromab pendetide (PROSTASCINT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN capromab pendetide
Brand PROSTASCINT
Route INTRAVENOUS
Formulation VIAL
Frequently asked questions
What is capromab pendetide?
capromab pendetide (PROSTASCINT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for capromab pendetide?
PROSTASCINT is a marketed brand name for capromab pendetide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of capromab pendetide?
capromab pendetide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.